logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Therapeutic Antibody Engineering Current And Future Advances Driving The Strongest Growth Area In The Pharmaceutical Industry 1st Edition William Strohl

  • SKU: BELL-4173474
Therapeutic Antibody Engineering Current And Future Advances Driving The Strongest Growth Area In The Pharmaceutical Industry 1st Edition William Strohl
$ 31.00 $ 45.00 (-31%)

4.7

46 reviews

Therapeutic Antibody Engineering Current And Future Advances Driving The Strongest Growth Area In The Pharmaceutical Industry 1st Edition William Strohl instant download after payment.

Publisher: Woodhead Publishing
File Extension: PDF
File size: 13.93 MB
Pages: 696
Author: William Strohl, Lila Strohl
ISBN: 9781907568374, 1907568379
Language: English
Year: 2012
Edition: 1

Product desciption

Therapeutic Antibody Engineering Current And Future Advances Driving The Strongest Growth Area In The Pharmaceutical Industry 1st Edition William Strohl by William Strohl, Lila Strohl 9781907568374, 1907568379 instant download after payment.

The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas.This book examines all aspects of engineering monoclonal antibodies to make them more competitive and looks at ways that the various genetic engineering approaches will affect candidates of the future. The authors go beyond the standard engineering issues (ADCC, CDC, half life engineering, etc.) that are covered by most books and delve into structure function relationships that will help to evolve new antibody structures beyond those already in clinical trials. Chapters discuss how current and future genetic engineering of cell lines will pave the way for much higher productivity, allowing for an overall decrease in cost of goods.

Related Products